China's CanSino Biologics said on Tuesday it had not started enrolling participants for a latestage trial of its potential COVID19 vaccine Ad5nCoV.from Top Business News- News18.com https://ift.tt/3g79QuX
China's CanSino says hasn't begun enrolling people for Phase 3 trial
China's CanSino Biologics said on Tuesday it had not started enrolling participants for a latestage trial of its potential COVID19 vaccine Ad5nCoV.from Top Business News- News18.com https://ift.tt/3g79QuX
Related Posts
Asia stocks cautiously mixed, dollar tries to bounce
ADB sees pandemic slashing 2020 global remittances by over $100 bln
Syria says U.S. oil firm signed deal with Kurdish-led rebels
China factory activity expands at fastest pace in nearly a decade-Caixin PMI
Exclusive: Trump to give TikTok's Chinese owner 45 days to agree sale - sources
0 comments: